Inhibrx Biosciences, Inc. INBX Earnings yield
Earnings yield at other companies
Other financials
Where this comes from
Calculated from Inhibrx Biosciences, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Inhibrx Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Inhibrx Biosciences, Inc.'s earnings yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Inhibrx Biosciences, Inc.'s earnings yield?
- Inhibrx Biosciences, Inc. (INBX) reported earnings yield of -13.3% in Q1 2026.
- How has Inhibrx Biosciences, Inc.'s earnings yield changed year-over-year?
- Inhibrx Biosciences, Inc.'s earnings yield decreased by 101.5% year-over-year, from 874.4% to -13.3%.
- What is the long-term trend for Inhibrx Biosciences, Inc.'s earnings yield?
- Over 2 years (2023 to 2025), Inhibrx Biosciences, Inc.'s earnings yield has grown at a -47.3% compound annual growth rate (CAGR), from -43.9% to -12.2%.
- What does earnings yield mean?
- Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.